SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
Activists march outside of Eli Lilly's offices at Alexandria Center for Life Science in New York City on September 5, 2019 (Photo: Erik McGregor/LightRocket via Getty Images)
Annual financial filings compiled by Axios Friday show that 10 of the nation's top healthcare CEOs took home more than $300 million in combined pay in 2019, compensation that Sen. Bernie Sanders denounced as "outrageous" and indicative of the industry's greed.
"While Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 healthcare CEOs made over $300 million in compensation last year," tweeted Sanders, a 2020 Democratic presidential candidate.
"We will end the greed of the pharmaceutical industry and pass Medicare for All," added Sanders, who has been targeted by industry-backed ad campaigns against universal healthcare.
\u201cWhile Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 health cares CEOs made over $300 million in compensation last year.\n\nOutrageous.\n\nWe will end the greed of the pharmaceutical industry and pass Medicare for All.\u201d— Bernie Sanders (@Bernie Sanders) 1583516703
Axios reported that the executives' eye-popping compensation in 2019 "mostly came from large stock gains."
Ari Bousbib, CEO of pharmaceutical data firm IQVIA, raked in more than $104 million in 2019, according to Axios' healthcare executive compensation tracker. Gary Guthart, CEO of clinical technology firm Intuitive Surgical CEO, brought home nearly $50.5 million. David Ricks, chief executive at pharmaceutical giant Eli Lilly, made over $30 million.
"The healthcare system is a firehose of spending," Axios noted, "and a good chunk of that money always makes its way to the top."
Donald Trump’s attacks on democracy, justice, and a free press are escalating — putting everything we stand for at risk. We believe a better world is possible, but we can’t get there without your support. Common Dreams stands apart. We answer only to you — our readers, activists, and changemakers — not to billionaires or corporations. Our independence allows us to cover the vital stories that others won’t, spotlighting movements for peace, equality, and human rights. Right now, our work faces unprecedented challenges. Misinformation is spreading, journalists are under attack, and financial pressures are mounting. As a reader-supported, nonprofit newsroom, your support is crucial to keep this journalism alive. Whatever you can give — $10, $25, or $100 — helps us stay strong and responsive when the world needs us most. Together, we’ll continue to build the independent, courageous journalism our movement relies on. Thank you for being part of this community. |
Annual financial filings compiled by Axios Friday show that 10 of the nation's top healthcare CEOs took home more than $300 million in combined pay in 2019, compensation that Sen. Bernie Sanders denounced as "outrageous" and indicative of the industry's greed.
"While Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 healthcare CEOs made over $300 million in compensation last year," tweeted Sanders, a 2020 Democratic presidential candidate.
"We will end the greed of the pharmaceutical industry and pass Medicare for All," added Sanders, who has been targeted by industry-backed ad campaigns against universal healthcare.
\u201cWhile Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 health cares CEOs made over $300 million in compensation last year.\n\nOutrageous.\n\nWe will end the greed of the pharmaceutical industry and pass Medicare for All.\u201d— Bernie Sanders (@Bernie Sanders) 1583516703
Axios reported that the executives' eye-popping compensation in 2019 "mostly came from large stock gains."
Ari Bousbib, CEO of pharmaceutical data firm IQVIA, raked in more than $104 million in 2019, according to Axios' healthcare executive compensation tracker. Gary Guthart, CEO of clinical technology firm Intuitive Surgical CEO, brought home nearly $50.5 million. David Ricks, chief executive at pharmaceutical giant Eli Lilly, made over $30 million.
"The healthcare system is a firehose of spending," Axios noted, "and a good chunk of that money always makes its way to the top."
Annual financial filings compiled by Axios Friday show that 10 of the nation's top healthcare CEOs took home more than $300 million in combined pay in 2019, compensation that Sen. Bernie Sanders denounced as "outrageous" and indicative of the industry's greed.
"While Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 healthcare CEOs made over $300 million in compensation last year," tweeted Sanders, a 2020 Democratic presidential candidate.
"We will end the greed of the pharmaceutical industry and pass Medicare for All," added Sanders, who has been targeted by industry-backed ad campaigns against universal healthcare.
\u201cWhile Americans continue to pay, by far, the highest prices in the world for prescription drugs, the top 10 health cares CEOs made over $300 million in compensation last year.\n\nOutrageous.\n\nWe will end the greed of the pharmaceutical industry and pass Medicare for All.\u201d— Bernie Sanders (@Bernie Sanders) 1583516703
Axios reported that the executives' eye-popping compensation in 2019 "mostly came from large stock gains."
Ari Bousbib, CEO of pharmaceutical data firm IQVIA, raked in more than $104 million in 2019, according to Axios' healthcare executive compensation tracker. Gary Guthart, CEO of clinical technology firm Intuitive Surgical CEO, brought home nearly $50.5 million. David Ricks, chief executive at pharmaceutical giant Eli Lilly, made over $30 million.
"The healthcare system is a firehose of spending," Axios noted, "and a good chunk of that money always makes its way to the top."